tumblr hit tracking tool
Recommended
23 September | Headline About Contact
Q&A tomorrow on NeoDynamics US launch
Anna Eriksrud 37 CEO, NeoDynamics
New Photo Voltaic Powered Mining Rigs
Ben Lukas 30 PR manager, Mecobit
Who is Responsible for Indoor Air at the Workplace?
Wilhelmina Linell 28 Group Marketing Communication Officer, Camfil

Healthcare

Q&A tomorrow on NeoDynamics US launch

By Anna Eriksrud 2022-09-21
The FDA approval for NeoNavia earlier this month is a critical step for NeoDynamics.
NeoDynamics to attend session with HC Andersen Capital. Will discuss planned US launch.

NeoDynamics today announced it would participate in a Q&A session with HC Andersen Capital on September 21 to discuss the company’s planned US launch of its innovative pulse biopsy system NeoNavia® after receiving approval from the US Food and Drug Administration, FDA, in September 2022.

The company is moving quickly to push its US strategy

“The FDA approval for NeoNavia earlier this month is a critical step for NeoDynamics as the US represents potentially the largest market for the product valued at $830 million by 2025,” said Anna Eriksrud, CEO of NeoDynamics.

Registration i open

“The company is moving quickly to push its US strategy, which is similar to the plan that is now being executed on in Europe.”

NeoDynamics’s CEO Anna Eriksrud, and CFO Aaron Wong will present at the Q&A.

Participants can register here to join the event on September 21 at 11:00 to 11.30 CEST.